Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cell Proliferation is Scopus-indexed (Q1, CiteScore 12.3), WoS SCIE, DOAJ. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 0960-7722Verify ISSN ↗1365-2184Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cell Biology | 42 / 289 | 85th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1984–present (also 1968–1982), best quartile Q1, CiteScore 12.3.
Cell Proliferation is Q1 in Cell Biology (rank 42 of 289), by CiteScore 2025.
Cell Proliferation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 12.3, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.985, quartile Q1, with an H-index of 110.
The publisher lists an article processing charge of about US$3,680 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cell Proliferation is published by Wiley-Blackwell Publishing Ltd. Its print ISSN is 0960-7722 and its online ISSN is 1365-2184.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cell Proliferation has an h-index of 139 and a 2-year mean of 5.92 citations per paper (OpenAlex). Its Scopus CiteScore is 12.3, quartile Q1. On 2-year citations it ranks #57 of 288 Scopus journals in Cell Biology.
Cell Proliferation published 209 papers in 2025; its busiest recent year was 2020 with 251. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from China (82.7%), United States (5.2%) and India (2.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 24 retracted papers are recorded (4.8 per 1,000 papers). The Problematic Paper Screener flags 4 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.